Caladrius Biosciences (CLBS) Reports Q4 Loss of $0.73/Share

Caladrius Biosciences (NASDAQ: CLBS) reported Q4 EPS of ($0.73), versus ($5.92) reported last year. Revenue for the quarter came in at $10.18 million, versus $7.56 million reported last year.

For earnings history and earnings-related data on Caladrius Biosciences (CLBS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c